Glucocorticoid receptor stimulation and the regulation of neonatal cerebellar neural progenitor cell apoptosis

Neurobiology of Disease

Volumn 43, Issue 2, 2011, Pages 356-363

  Noguchi, Kevin K ^a   Lau, Karen ^a   Smith, Derek J ^a   Swiney, Brant S ^a   Farber, Nuri B ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Betamethasone; Bronchopulmonary dysplasia; Cerebellum; Chronic lung disease; Dexamethasone; Glucocorticoid; Neural progenitor cell; Neurodevelopment; Premature birth

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; BETAMETHASONE; CARBENOXOLONE; CORTICOSTERONE; CYTARABINE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; CELL GRANULE; CELL POPULATION; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME INHIBITION; FEMALE; MALE; MOUSE; NEURAL STEM CELL; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL DIFFERENTIATION; CEREBELLUM; CORTICOSTERONE; MICE; MICE, INBRED ICR; NEUROGENESIS; RECEPTORS, GLUCOCORTICOID; STEM CELLS;

EID: 79958235622     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.04.004     Document Type: Article

References (46)

1. Altman J., Bayer S.A. Development of the Cerebellar System: In Relation to its Evolution, Structure, and Functions 1997, CRC Press, Boca Raton.
2. Amaral D.G., Schumann C.M., Nordahl C.W. Neuroanatomy of autism. Trends Neurosci. 2008, 31:137-145.
3. Andersen B.B., et al. A quantitative study of the human cerebellum with unbiased stereological techniques. J. Comp. Neurol. 1992, 326:549-560.
4. Benders M.J., et al. Brain development of the preterm neonate after neonatal hydrocortisone treatment for chronic lung disease. Pediatr. Res. 2009, 66:555-559.
5. Benesova O., Pavlik A. Brain glucocorticoid receptors and their role in behavioural teratogenicity of synthetic glucocorticoids. Arch. Toxicol. Suppl. 1985, 8:73-76.
6. Benesova O., Pavlik A. Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain. Neuropharmacology 1989, 28:89-97.
7. Bohn M.C., Lauder J.M. Cerebellar granule cell genesis in the hydrocortisone-treated rats. Dev. Neurosci. 1980, 3:81-89.
8. Committee on Fetus and Newborn Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002, 109:330-338.
9. Dakine N., et al. Effects of experimental hypothyroidism on the development of the hypothalamo-pituitary-adrenal axis in the rat. Life Sci. 2000, 67:2827-2844.
10. de la Rosa E.J., de Pablo F. Cell death in early neural development: beyond the neurotrophic theory. Trends Neurosci. 2000, 23:454-458.
11. De Zio D., Giunta L., Corvaro M., Ferraro E., Cecconi F. Expanding roles of programmed cell death in mammalian neurodevelopment. Semin. Cell Dev. Biol. 2005, 16:281-294.
12. Depaepe V., et al. Ephrin signalling controls brain size by regulating apoptosis of neural progenitors. Nature 2005, 435:1244-1250.
13. Eventov-Friedman S., Shinwell E.S. Current controversies in perinatal steroid therapy. Acta Paediatr. 2008, 97:1492-1501.
14. Ferguson S.A., Holson R.R. Neonatal dexamethasone on day 7 causes mild hyperactivity and cerebellar stunting. Neurotoxicol. Teratol. 1999, 21:71-76.
15. Gould E., et al. Adrenal steroids regulate postnatal development of the rat dentate gyrus: I. Effects of glucocorticoids on cell death. J. Comp. Neurol. 1991, 313:479-485.
16. Harvey R.J., Napper R.M. Quantitative study of granule and Purkinje cells in the cerebellar cortex of the rat. J. Comp. Neurol. 1988, 274:151-157.
17. Haydar T.F., et al. The role of cell death in regulating the size and shape of the mammalian forebrain. Cereb. Cortex 1999, 9:621-626.
18. Heine V.M., Rowitch D.H. Hedgehog signaling has a protective effect in glucocorticoid-induced mouse neonatal brain injury through an 11betaHSD2-dependent mechanism. J. Clin. Invest. 2009, 119:267-277.
19. Holmes M.C., et al. 11beta-Hydroxysteroid dehydrogenase type 2 protects the neonatal cerebellum from deleterious effects of glucocorticoids. Neuroscience 2006, 137:865-873.
20. Jung-Testas I., Baulieu E.E. Inhibition of glucocorticosteroid action in cultured L-929 mouse fibroblasts by RU 486, a new anti-glucocorticosteroid of high affinity for the glucocorticosteroid receptor. Exp. Cell Res. 1983, 147:177-182.
21. Keil D.E., et al. Differences in the effects of dexamethasone on macrophage nitrite production: dependence on exposure regimen (in vivo or in vitro) and activation stimuli. Int. J. Immunopharmacol. 1995, 17:157-166.
22. Kuida K., et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996, 384:368-372.
23. Kuida K., et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998, 94:325-337.
24. Lodygensky G.A., et al. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease. Pediatrics 2005, 116:1-7.
25. Matthews S.G., et al. Fetal glucocorticoid exposure and hypothalamo-pituitary-adrenal (HPA) function after birth. Endocr. Res. 2004, 30:827-836.
26. Mesripour A., Hajhashemi V., Rabbani M. Metyrapone and mifepristone reverse recognition memory loss induced by spontaneous morphine withdrawal in mice. Basic Clin. Pharmacol. Toxicol. 2008, 102:377-381.
27. Murphy K.E., et al. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet 2008, 372:2143-2151.
28. National Institutes of Health Antenatal corticosteroids revisited: repeat courses. NIH Consens. Statement 2000, 17:1-18.
29. Noguchi K.K., et al. Acute neonatal glucocorticoid exposure produces selective and rapid cerebellar neural progenitor cell apoptotic death. Cell Death Differ. 2008, 15:1582-1592.
30. Onland W., et al. Finding the optimal postnatal dexamethasone regimen for preterm infants at risk of bronchopulmonary dysplasia: a systematic review of placebo-controlled trials. Pediatrics 2009, 123:367-377.
31. Parikh N.A., Lasky R.E., Kennedy K.A., Moya F.R., Hochhauser L., Romo S., Tyson J.E. Postnatal dexamethasone therapy and cerebral tissue volumes in extremely low birth weight infants. Pediatrics 2007, 119:265-272.
32. Pavlik A., Buresova M. The neonatal cerebellum: the highest level of glucocorticoid receptors in the brain. Brain Res. 1984, 314:13-20.
33. Pedraz J.L., Lanao J.M., Dominguez-Gil A. Interspecies pharmacokinetics of ketamine. Status of Ketamine in Anesthesiology 1990, 285-295. NPP Books, Ann Arbor. E.F. Domino (Ed.).
34. Peltoniemi O.M., et al. Trial of early neonatal hydrocortisone: two-year follow-up. Neonatology 2009, 95:240-247.
35. Rademaker K.J., de Vries W.B. Long-term effects of neonatal hydrocortisone treatment for chronic lung disease on the developing brain and heart. Semin. Fetal Neonatal Med. 2009, 14:171-177.
36. Rademaker K.J., et al. Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm-born children. J. Pediatr. 2007, 150:351-357.
37. Robson A.C., et al. 11 Beta-hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain. Brain Res. 1998, 61:1-10.
38. Schimmer B.P., Parker K.L. Chapter 59. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. Goodman and Gilman's The Pharmacological Basis of Therapeutics 2006, 1587-1612. The McGraw-Hill Companies, Inc., New York. 11th ed. L.L. Brunton, J.S. Lazo, K.L. Parker (Eds.).
39. Schmidt M.V., et al. The HPA system during the postnatal development of CD1 mice and the effects of maternal deprivation. Brain Res. 2002, 139:39-49.
40. Schmidt M.V., et al. The postnatal development of the hypothalamic-pituitary-adrenal axis in the mouse. Int. J. Dev. Neurosci. 2003, 21:125-132.
41. Tanaka M., Marunouchi T. Immunohistochemical analysis of developmental stage of external granular layer neurons which undergo apoptosis in postnatal rat cerebellum. Neurosci. Lett. 1998, 242:85-88.
42. Volpe J.J. Encephalopathy of prematurity includes neuronal abnormalities. Pediatrics 2005, 116:221-225.
43. Watterberg K.L., et al. Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants. Pediatrics 2007, 120:40-48.
44. Yeh T.F., et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N. Engl. J. Med. 2004, 350:1304-1313.
45. Yehuda R., Meyer J.S. Regional patterns of brain growth during the first three weeks following early adrenalectomy. Physiol. Behav. 1991, 49:233-237.
46. Yehuda R., et al. Enhanced brain cell proliferation following early adrenalectomy in rats. J. Neurochem. 1989, 53:241-248.